Annotation Detail for NLGN3
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04514 | Cell adhesion molecules (CAMs) |
Desease Name |
---|
Autism, susceptibility to, X-linked-1 |
Asperger syndrome, susceptibility to, X-linked-1 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NLGN3 mRNA | affects expression | 16483693
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of NLGN3 gene | increases mutagenesis | 16495775
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of NLGN3 mRNA | decreases expression | 18035473
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.94 | 6695378 |
OMIM:300494 |
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
OMIM:300425 |
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1 |
marker/mechanism |
|
| |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 12669065 18621663 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.33 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.74 | 16436596 16357521 18412241 15144691 16651633 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
4.01 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.85 | 17160924 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.85 | 18357618 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
4.10 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.63 | 16651633 16357521 18412241 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.84 | 17296493 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
4.32 | 17379185 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.63 | 16271038 6695378 17703301 16019985 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.25 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.70 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.77 | 10838139 10767621 18041768 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.85 | 17943659 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
5.05 | 16707424 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
6.16 | 16651423 16003739 17160924 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.85 | 17160924 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.90 | 15790496 |
Pathway ID |
Pathway Name |
---|
KEGG:04514 |
Cell adhesion molecules (CAMs) |
PharmGKB Accession:PA31649
Releated disease ID |
Related disease Name |
PA447198 | Autistic Disorder |